Literature DB >> 11205212

Sensitivity of serum tumor markers CEA and CA 15-3 in breast cancer recurrences and correlation with different prognostic factors.

F Lumachi1, A A Brandes, M Ermani, G Bruno, P Boccagni.   

Abstract

The aim of this study was to evaluate the correlation between serum tumor markers CEA and CA 15-3 in breast cancer (BC) patients with disease relapse and different prognostic parameters at first operation. Sixty-two women (median age 55 years, range 35-83 years) who had undergone curative surgery for pT1-2 pN0-1 M0 breast cancer developed local recurrences, distant metastases or contralateral BC during a median relapse time of 53 months (range 25-149 months). Sensitivity of CEA, CA 15-3, and CEA + CA 15-3 together was 40.3%, 41.9% and 59.7%, respectively. No correlation (p = NS) was found between tumor markers sensitivity and type of recurrence, surgical procedure, histologic subtypes and hormone receptors rate. CEA significantly (p < 0.01) correlated with the size of the tumor and axillary node status and CA 15-3 with the age of the patients. In conclusion, CEA and CA 15-3 should be considered complementary in detecting BC recurrences but their sensitivity is low and independent of the majority of the prognostic parameters that may be considered before relapse.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11205212

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  10 in total

1.  Evaluation and identification of microRNA-106 in the diagnosis of cancer: a meta-analysis.

Authors:  Bo Zhang; Chun-Wei Xu; Yun Shao; Huai-Tao Wang; Yong-Fang Wu; Ye-Ying Song; Xiao-Bing Li; Wen-Bin Gao; Wen-Bo Liang
Journal:  Int J Clin Exp Med       Date:  2014-10-15

2.  Long-term prognostic study of carcinoembryonic antigen (CEA) and carbohydrate antigen 15-3 (CA 15-3) in breast cancer.

Authors:  Masahiro Uehara; Takayuki Kinoshita; Takashi Hojo; Sadako Akashi-Tanaka; Eriko Iwamoto; Takashi Fukutomi
Journal:  Int J Clin Oncol       Date:  2008-10-23       Impact factor: 3.402

Review 3.  MicroRNAs (miRNAs) as biomarker(s) for prognosis and diagnosis of gastrointestinal (GI) cancers.

Authors:  Muzafar A Macha; Parthasarathy Seshacharyulu; Shiv Ram Krishn; Priya Pai; Satyanarayana Rachagani; Maneesh Jain; Surinder K Batra
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

4.  Elevated preoperative serum cancer antigen 15.3 levels are associated with reduced disease-free survival: a single-institution experience.

Authors:  Eyad Fawzi Alsaeed; Huda Abdulkarim; Mutahir A Tunio
Journal:  Breast Cancer (Dove Med Press)       Date:  2013-07-26

5.  Cancer diagnosis and prognosis decoded by blood-based circulating microRNA signatures.

Authors:  Dharanija Madhavan; Katarina Cuk; Barbara Burwinkel; Rongxi Yang
Journal:  Front Genet       Date:  2013-06-21       Impact factor: 4.599

Review 6.  Potential Role of MicroRNA-210 as Biomarker in Human Cancers Detection: A Meta-Analysis.

Authors:  Jiongjiong Lu; Feng Xie; Li Geng; Weifeng Shen; Chengjun Sui; Jiamei Yang
Journal:  Biomed Res Int       Date:  2015-09-13       Impact factor: 3.411

Review 7.  Potential role of microRNA-126 in the diagnosis of cancers: A systematic review and meta-analysis.

Authors:  Jin Yan; Shijie Ma; Yifeng Zhang; Chengqiang Yin; Xiaoying Zhou; Guoxin Zhang
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

Review 8.  Potential Role of MicroRNA-375 as Biomarker in Human Cancers Detection: A Meta-Analysis.

Authors:  Jin Yan; Qiang She; Xiaoran Shen; Yifeng Zhang; Bingtuan Liu; Guoxin Zhang
Journal:  Biomed Res Int       Date:  2017-11-13       Impact factor: 3.411

9.  A Combined Analysis of Serum Growth Differentiation Factor-15 and Cancer Antigen 15-3 Enhances the Diagnostic Efficiency in Breast Cancer.

Authors:  Anupama Modi; Purvi Purohit; Ashita Gadwal; Dipayan Roy; Sujoy Fernandes; Jeewan Ram Vishnoi; Puneet Pareek; Poonam Elhence; Sanjeev Misra; Praveen Sharma
Journal:  EJIFCC       Date:  2021-10-18

10.  Predictive Value of Circulating Tumor Cells for Evaluating Short- and Long-Term Efficacy of Chemotherapy for Breast Cancer.

Authors:  Shihui Ma; Feihai Ling; Anping Gui; Shifeng Chen; Yanxiang Sun; Zhou Li
Journal:  Med Sci Monit       Date:  2017-10-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.